QTTBQ32 Bio Inc.

$83M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$392,000-57.7% YoY

Gross Profit

$00.0% margin

Operating Income

-$28M-7136.0% margin

Net Income

-$26M-6701.5% margin

EPS (Diluted)

$-10.98

QoQ Revenue Growth

+45.2%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$341M

Total Liabilities

$56M

Stockholders' Equity

$285M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$392,000	$926,477	-57.7%
Gross Profit	$0	$0	—
Operating Income	-$28M	-$14M	-101.4%
Net Income	-$26M	-$13M	-103.7%

QTTB Q2 2019 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena